Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
51.33
P/B ratioShare price divided by book value per share.
0.87
P/S ratioMarket value divided by annual revenue.
1.14
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
11.02
EV / RevenueEnterprise value against annual revenue.
0.99
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
1.95%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
16.94%
Operating marginRevenue left after operating costs.
6.00%
Net marginRevenue left after every cost, including tax and interest.
2.15%
Return on equityProfit as a percentage of shareholders’ equity.
2.66%
Return on assetsProfit as a percentage of total assets.
2.04%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.62
Quick ratioThe same, excluding inventory.
2.97
Debt to equityTotal borrowings against shareholders’ equity.
0.06
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.06
Book value per shareShareholders’ equity divided by shares outstanding.
$3.55
Shares outstandingShares currently issued.
1,943,851,868
Market capitalisationShare price times shares outstanding.
$5.99B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
4,702
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
2.88%
Payout ratioShare of profit paid out as dividends.
What is Guizhou Xinbang Pharmaceutical Co., Ltd.'s P/E ratio?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) trades on a price-to-earnings ratio of 51.33.
What is Guizhou Xinbang Pharmaceutical Co., Ltd.'s return on equity?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) reports a return on equity of 2.66%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Guizhou Xinbang Pharmaceutical Co., Ltd. carry?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) has a debt-to-equity ratio of 0.06, which compares total borrowings with shareholders' equity.
What is Guizhou Xinbang Pharmaceutical Co., Ltd.'s profit margin?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) keeps 2.15% of revenue as net profit after every cost, including tax and interest.